For Doctors · Narrative review

Management of Varicose Tributaries: Phlebectomy, Foam Sclerotherapy and Timing Relative to Truncal Ablation

By Dr Johan Blignaut, Specialist Surgeon · Vein Centres South Africa · October 2026

Written for general practitioners and other clinicians. This page summarises the review; the full text, tables and references are in the PDF.

Abstract

Varicose tributaries often persist after endovenous ablation of an incompetent saphenous trunk, and their management is one of the most common decisions in venous practice.

Ambulatory phlebectomy and ultrasound-guided foam sclerotherapy (UGFS) are both endorsed by current European, American and UK guidance, but how they compare is less clear. This narrative review summarises the evidence on efficacy, safety, timing and cost.

Direct comparative evidence is limited to three small randomised trials of foam versus phlebectomy and an older trial that used liquid rather than foam sclerosant; adequately powered trials remain unpublished or under way. On that evidence, phlebectomy may be more durable, while foam causes less early pain and bruising and allows a faster return to work, at the cost of more pigmentation.

Treating tributaries at the same sitting as truncal ablation reduces re-intervention in pooled data, including a meta-analysis restricted to randomised trials, although the accompanying quality-of-life gains are small and early. A tributary-first strategy that preserves the saphenous trunk (ASVAL) was non-inferior in quality of life in one large trial, but a quarter of patients needed later truncal treatment.

Most practical choices between the two techniques still rest on anatomy, patient priorities and expert consensus rather than trial data.

Key points

1. Both techniques are guideline-endorsed. Ambulatory phlebectomy and ultrasound-guided foam sclerotherapy are recommended for varicose tributaries in current European, American and UK guidance.
2. Head-to-head evidence is thin. It rests on three small randomised trials of foam versus phlebectomy and an older trial using liquid sclerosant; the adequately powered comparison remains unpublished.
3. Phlebectomy may be more durable; foam causes less early pain and bruising and a faster return to work (3.6 vs 13.7 days in one trial), at the cost of more pigmentation.
4. Concomitant treatment reduces re-intervention. Treating tributaries at the same sitting as truncal ablation reduced re-intervention in pooled data, including a 2026 meta-analysis of randomised trials (RR 0.33), but the quality-of-life gains are small and early.
5. Staging remains reasonable for smaller or uncertain tributaries, reassessed by duplex, and spares some patients any tributary procedure.
6. ASVAL is an option for selected patients. In SAPTAP it was non-inferior for quality of life at 12 months, but 25.6% later needed truncal treatment.
7. Match the technique to the vein. Large, palpable tributaries suit phlebectomy; tortuous, deep, non-palpable, ankle and residual veins often suit foam. Many patients receive both.
8. Most day-to-day choices rest on anatomy, patient priorities and consensus, not trial data — the review labels which recommendations are evidence-based and which are practice-based.

What the full review covers

• Introduction and background
• Methods: search strategy and study selection
• The two techniques compared
• How success is measured
• Randomised trials of foam versus phlebectomy
• Safety and complications, including foam-specific risks
• Timing: concomitant, staged or tributaries first (ASVAL)
• Choosing between the techniques: a decision table
• Proposed decision pathway
• Costs and aftercare
• Other options and evidence gaps
• Limitations and conclusions

How to cite

Blignaut J. Management of Varicose Tributaries: Phlebectomy, Foam Sclerotherapy and Timing Relative to Truncal Ablation. Narrative review. Vein Centres South Africa; October 2026. Available from: https://www.veinsurgery.co.za/articles/doctors/varicose-tributaries-foam-sclerotherapy-phlebectomy.html

Disclosure. The author performs both procedures in private practice, which may influence the practice-based recommendations; these are labelled as such in the review. This is a narrative review by a single author without formal risk-of-bias assessment or meta-analysis. It is for medical education and does not replace individual clinical assessment.